Blueprint Medicines Statistics
Total Valuation
DTI has a market cap or net worth of $81.15 million. The enterprise value is $157.13 million.
Important Dates
The next confirmed earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DTI has 35.59 million shares outstanding. The number of shares has increased by 20.76% in one year.
| Current Share Class | 35.59M |
| Shares Outstanding | 35.59M |
| Shares Change (YoY) | +20.76% |
| Shares Change (QoQ) | +2.56% |
| Owned by Insiders (%) | 7.95% |
| Owned by Institutions (%) | 11.24% |
| Float | 15.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 72.68 |
| PS Ratio | 0.47 |
| Forward PS | 0.53 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 15.68 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.98 |
| EV / EBITDA | 4.27 |
| EV / EBIT | 13.54 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.94 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | n/a |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is -1.66% and return on invested capital (ROIC) is 4.31%.
| Return on Equity (ROE) | -1.66% |
| Return on Assets (ROA) | 3.62% |
| Return on Invested Capital (ROIC) | 4.31% |
| Return on Capital Employed (ROCE) | 5.85% |
| Revenue Per Employee | $358,729 |
| Profits Per Employee | -$3,984 |
| Employee Count | 447 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 2.53 |
Taxes
| Income Tax | -1.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.55% in the last 52 weeks. The beta is -0.41, so DTI's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | -50.55% |
| 50-Day Moving Average | 2.70 |
| 200-Day Moving Average | 2.89 |
| Relative Strength Index (RSI) | 43.09 |
| Average Volume (20 Days) | 35,895 |
Short Selling Information
The latest short interest is 228,910, so 0.64% of the outstanding shares have been sold short.
| Short Interest | 228,910 |
| Short Previous Month | 276,918 |
| Short % of Shares Out | 0.64% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 1.47 |
Income Statement
In the last 12 months, DTI had revenue of $160.35 million and -$1.78 million in losses. Loss per share was -$0.06.
| Revenue | 160.35M |
| Gross Profit | 119.15M |
| Operating Income | 11.60M |
| Pretax Income | 14.40M |
| Net Income | -1.78M |
| EBITDA | 36.79M |
| EBIT | 11.60M |
| Loss Per Share | -$0.06 |
Full Income StatementBalance Sheet
The company has $2.79 million in cash and $78.77 million in debt, giving a net cash position of -$75.98 million or -$2.13 per share.
| Cash & Cash Equivalents | 2.79M |
| Total Debt | 78.77M |
| Net Cash | -75.98M |
| Net Cash Per Share | -$2.13 |
| Equity (Book Value) | 122.70M |
| Book Value Per Share | 3.45 |
| Working Capital | 32.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.18 million and capital expenditures -$21.71 million, giving a free cash flow of -$16.53 million.
| Operating Cash Flow | 5.18M |
| Capital Expenditures | -21.71M |
| Free Cash Flow | -16.53M |
| FCF Per Share | -$0.46 |
Full Cash Flow StatementMargins
Gross margin is 74.31%, with operating and profit margins of 7.23% and -1.11%.
| Gross Margin | 74.31% |
| Operating Margin | 7.23% |
| Pretax Margin | -1.81% |
| Profit Margin | -1.11% |
| EBITDA Margin | 22.94% |
| EBIT Margin | 7.23% |
| FCF Margin | n/a |
Dividends & Yields
DTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.76% |
| Shareholder Yield | -20.76% |
| Earnings Yield | -2.19% |
| FCF Yield | -20.37% |
Analyst Forecast
The average price target for DTI is $5.50, which is 143.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.50 |
| Price Target Difference | 143.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DTI has an Altman Z-Score of 1.72 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | 4 |
